NEW YORK – Results of a recent study have found that motor and non-motor assessments through virtual research visits are feasible in individuals with Parkinson’s Disease.
The telehealth study was conducted through the University of Rochester Medical Center in collaboration with real-time virtual care solutions provider AMC Health.
“We are very encouraged by these interim results that demonstrate the value of offering eVisits to clinical trial participants to reduce their burden, and leads to the likelihood that more patients will participate in clinical trials in the future,” said Michael O’Brien, president of the Clinical Trials Division of AMC Health, in a statement.
The study is a sub-study of a larger National Institutes of Health-funded Phase 3 trial, which assessed the feasibility, reliability and value of deploying virtual eVisits in a Parkinson’s Disease study population compared to traditional in-person visits.
The virtual visit deploys a smartphone, which provides a secure video connection between the study subject at home and the clinical study team. During the eVisit session, blood pressure and weight measurements are collected via Bluetooth sensor devices, and a series of motor and non-motor assessments are conducted by the study team and entered through on-screen clinical assessment workflows.
The study also included patient-reported assessments to determine ease of use, patient satisfaction and the likelihood that patients believe virtual visits would benefit future trials.
“We hope this study will lay the foundation for bringing clinical trials to participants in the future,” said Dr. Ray Dorsey, professor of neurology and director of the Center for Human Experimental Therapeutics at the University of Rochester Medical Center, in a statement. “Clinical trials should reduce, not increase, the burden on those that volunteer to participate in them.”